Eric Easom - Net Worth and Insider Trading
Eric Easom Net Worth
The estimated net worth of Eric Easom is at least $2 Million dollars as of 2025-07-23. Eric Easom is the CEO of AN2 Therapeutics Inc and owns about 1,516,262 shares of AN2 Therapeutics Inc (ANTX) stock worth over $2 Million. Details can be seen in Eric Easom's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Easom has not made any transactions after 2025-06-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Easom
Eric Easom Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Easom owns 1 companies in total, including AN2 Therapeutics Inc (ANTX) .
Click here to see the complete history of Eric Easom’s form 4 insider trades.
Insider Ownership Summary of Eric Easom
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2025-06-02 | director & Chief Executive Officer |
Eric Easom Latest Holdings Summary
Eric Easom currently owns a total of 1 stock. Eric Easom owns 1,516,262 shares of AN2 Therapeutics Inc (ANTX) as of June 2, 2025, with a value of $2 Million.
Latest Holdings of Eric Easom
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics Inc | 2025-06-02 | 1,516,262 | 1.11 | 1,683,051 |
Holding Weightings of Eric Easom
Eric Easom Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Easom has made a total of 11 transactions in AN2 Therapeutics Inc (ANTX) over the past 5 years, including 3 buys and 8 sells. The most-recent trade in AN2 Therapeutics Inc is the acquisition of 10,000 shares on June 2, 2025, which cost Eric Easom around $10,700.
Insider Trading History of Eric Easom
- 1
Eric Easom Trading Performance
GuruFocus tracks the stock performance after each of Eric Easom's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Easom is 36.27%. GuruFocus also compares Eric Easom's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Easom within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric Easom's insider trading performs compared to the benchmark.
Performance of Eric Easom
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.28 | | | | | |
| Relative Return to S&P 500(%) | 18.43 | | | | | |
Eric Easom Ownership Network
Ownership Network List of Eric Easom
Ownership Network Relation of Eric Easom
Eric Easom Owned Company Details
What does AN2 Therapeutics Inc do?
Who are the key executives at AN2 Therapeutics Inc?
Eric Easom is the director & Chief Executive Officer of AN2 Therapeutics Inc. Other key executives at AN2 Therapeutics Inc include Chief Development Officer Sanjay Chanda , Chief Financial Officer Lucy Day , and See Remarks Joshua M Eizen .
AN2 Therapeutics Inc (ANTX) Insider Trades Summary
Over the past 18 months, Eric Easom made 2 insider transaction in AN2 Therapeutics Inc (ANTX) with a net purchase of 60,000. Other recent insider transactions involving AN2 Therapeutics Inc (ANTX) include a net sale of 1,232,000 shares made by Braden Michael Leonard , a net purchase of 335,000 shares made by Robin Shane Readnour , and a net purchase of 27,000 shares made by Joseph S Zakrzewski .
In summary, during the past 3 months, insiders sold 2,732,000 shares of AN2 Therapeutics Inc (ANTX) in total and bought 18,610 shares, with a net sale of 2,713,390 shares. During the past 18 months, 6,274,700 shares of AN2 Therapeutics Inc (ANTX) were sold and 1,930,610 shares were bought by its insiders, resulting in a net sale of 4,344,090 shares.
AN2 Therapeutics Inc (ANTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AN2 Therapeutics Inc Insider Transactions
Eric Easom Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Easom. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Eric Easom's mailing address is: Menlo Park Ca 94025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
